Could STERIS plc (STE) See a Reversal After Breaking Its 52-Week High?

May 25, 2018 - By reb123z

STERIS plc (NYSE:STE) Logo

Investors sentiment decreased to 0.17 in 2017 Q4. Its down 0.33, from 0.5 in 2017Q3. It fall, as 4 investors sold STERIS plc shares while 2 reduced holdings. 1 funds opened positions while 0 raised stakes. 19,649 shares or 85.67% less from 137,131 shares in 2017Q3 were reported.
Fruth Inv Mgmt holds 14,076 shares or 0.52% of its portfolio. Prudential Public Limited Company holds 3,800 shares or 0% of its portfolio. Shine Advisory Service Inc holds 0.01% in STERIS plc (NYSE:STE) or 123 shares. Alphamark Advisors has 150 shares for 0.01% of their portfolio. Hanson & Doremus Investment Management invested in 1,500 shares or 0.04% of the stock.

The stock of STERIS plc (NYSE:STE) hit a new 52-week high and has $106.93 target or 3.00 % above today’s $103.82 share price. The 9 months bullish chart indicates low risk for the $8.81B company. The 1-year high was reported on May, 25 by Barchart.com. If the $106.93 price target is reached, the company will be worth $264.27M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.64% or $0.67 during the last trading session, reaching $103.82. About 94,949 shares traded. STERIS plc (NYSE:STE) has risen 32.31% since May 25, 2017 and is uptrending. It has outperformed by 20.76% the S&P500.

Analysts await STERIS plc (NYSE:STE) to report earnings on August, 14. They expect $0.98 earnings per share, up 15.29 % or $0.13 from last year’s $0.85 per share. STE’s profit will be $83.15 million for 26.48 P/E if the $0.98 EPS becomes a reality. After $1.24 actual earnings per share reported by STERIS plc for the previous quarter, Wall Street now forecasts -20.97 % negative EPS growth.

STERIS plc (NYSE:STE) Ratings Coverage

Among 3 analysts covering STERIS (NYSE:STE), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. STERIS had 3 analyst reports since January 3, 2018 according to SRatingsIntel. Northcoast maintained STERIS plc (NYSE:STE) rating on Thursday, February 8. Northcoast has “Buy” rating and $102.0 target. The stock of STERIS plc (NYSE:STE) has “Buy” rating given on Thursday, February 8 by KeyBanc Capital Markets. The stock has “Market Perform” rating by Raymond James on Wednesday, January 3.

Another recent and important STERIS plc (NYSE:STE) news was published by Seekingalpha.com which published an article titled: “STERIS Plc (STE) Q4 2018 Results – Earnings Call Transcript” on May 09, 2018.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide. The company has market cap of $8.81 billion. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It has a 36.57 P/E ratio. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

STERIS plc (NYSE:STE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: